Selenium deficiency increases the risk of certain cancers and selenium supplementation in deficient locales has demonstrated chemopreventative benefits in several cancers. While developing a model to better understand the relationship between inflammation and cancer, a novel method of inactivation of the tumor suppressor, p53, by electrophilic lipids was elucidated. This mechanism involves the selenoprotein thioredoxin reductase (TrxR) and is selenium dependent. The overall objective of this study is to understand how selenoproteins contribute to cellular processes of transcriptional regulation and cell death by regulating the redox state of the cell. This application tests the hypothesis that TrxR can function as a molecular switch, from contributing reducing equivalents to functioning as a pro-oxidant within the cell upon attack by certain electrophiles. The expectation is that this functional switch has important cellular consequences. It influences the tumor suppressor, p53, as well as redox sensitive processes in protein turnover, and cellular responses to renormalize redox tone. In addition, the 'TrxR-function switch' can promote other cellular processes like cell death. To test these hypotheses, the specific aims are:
Aim 1 : Determine the precise mechanism of p53 inactivation by attenuation of TrxR activity. Is the oxidation state of p53 directly altered by electrophilic lipids or by selenium-compromised TrxR? Furthermore, is a similar mechanism responsible for proteasome pathway inhibition observed by certain electrophilic lipids? Aim 2: Determine roles for TrxR in apoptosis. Is the proposed switch of TrxR function responsible for selenium-compromised TrxR induction of apoptosis and, is fully-functional TrxR necessary for selenium-induced apoptosis? Aim 3: Determine the role that selenoprotein P (SelP) plays in response to lipoxygenase induction and TrxR activity attenuation. Does SelP have a novel function in the regulation of lipid hydroperoxides? These studies provide an integrated framework to understand how electrophiles and selenium/selenoproteins contribute to the etiology of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA115616-01
Application #
6955370
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Yassin, Rihab R,
Project Start
2005-06-10
Project End
2009-05-31
Budget Start
2005-06-10
Budget End
2006-05-31
Support Year
1
Fiscal Year
2005
Total Cost
$265,934
Indirect Cost
Name
University of Utah
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Cassidy, Pamela B; Fain, Heidi D; Cassidy Jr, James P et al. (2013) Selenium for the prevention of cutaneous melanoma. Nutrients 5:725-49
Poerschke, Robyn L; Franklin, Michael R; Bild, Andrea H et al. (2012) Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. J Biochem Mol Toxicol 26:344-53
Poerschke, Robyn L; Moos, Philip J (2011) Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction. Biochem Pharmacol 81:211-21
Rock, Colleen; Moos, Philip J (2010) Selenoprotein P protects cells from lipid hydroperoxides generated by 15-LOX-1. Prostaglandins Leukot Essent Fatty Acids 83:203-10
Edes, Kornelia; Cassidy, Pamela; Shami, Paul J et al. (2010) JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1. PLoS One 5:e8786
Honeggar, Matthew; Beck, Robert; Moos, Philip J (2009) Thioredoxin reductase 1 ablation sensitizes colon cancer cells to methylseleninate-mediated cytotoxicity. Toxicol Appl Pharmacol 241:348-55
Rock, Colleen; Moos, Philip J (2009) Selenoprotein P regulation by the glucocorticoid receptor. Biometals 22:995-1009
Poerschke, Robyn L; Franklin, Michael R; Moos, Philip J (2008) Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid. Toxicol In Vitro 22:1761-7
Cordray, Pauline; Doyle, Kelly; Edes, Kornelia et al. (2007) Oxidation of 2-Cys-peroxiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cyclooxygenase-2. J Biol Chem 282:32623-9
Cassidy, Pamela B; Edes, Kornelia; Nelson, Chad C et al. (2006) Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis 27:2538-49